CSF parameters |
Total cases (100) |
WBCs (total cells /ul ) |
|
≤100 |
52 |
>100–1000 |
28 |
>1000 |
20 |
Cell type : Neutrophils% |
|
>50 |
30 |
<50 |
70 |
Protein (mg/dL) |
|
<50 |
75 |
>50 |
25 |
Glucose (mg/dL) |
|
>45 |
70 |
<45 |
30 |
Sl
No. |
Organisms |
Total
no of cases |
Percentage |
1 |
Escherichia
coli |
8 |
32% |
2 |
Streptococcus
pneumoniae |
4 |
16% |
3 |
Klebsiella
pneumoniae |
4 |
16% |
4 |
Group B Streptococci |
2 |
8% |
5 |
Pseudomonas
aeruginosa |
2 |
8% |
6 |
Staphylococcus
aureus |
2 |
8% |
7 |
Enterococcus
faecalis |
1 |
4% |
8 |
Enterobacteraerogenes |
1 |
4% |
9 |
Citrobacter
koseri |
1 |
4% |
Total |
25 |
100% |
Antibiotic |
Percentage |
Imipenem |
100 % |
Pipercillin/Tazobactum |
90% |
Amikacin |
85% |
Cefatazidime/
Clauvnic acid |
85% |
Ceftoxime |
75% |
Cefatazidime |
77% |
Levofloxacin |
80% |
Ofloxacin |
77% |
Amoxicillin/Clauvnic
acid |
72% |
Co-tirmoxazole |
67% |